COVID-19 Monoclonal Antibody Study
A press release was issued by Eli Lilly on Dec. 4, 2020 about a COVID-19 monoclonal antibody study being conducted in partnership with UnitedHealth Group. The national, 500,000-person pragmatic study will test their new monoclonal antibody treatment for people recently diagnosed with COVID-19. This treatment was authorized by the U.S. Food & Drug Administration for emergency use.
This study will be offered to UnitedHealthcare Medicare Advantage members in 46 states who meet the study’s criteria for participation. Information about the study, including selection criteria and how UnitedHealthcare members can volunteer to be considered for the study, can be found at unitedinresearch.com.
Last update: November 25, 2020, 2:30 p.m. CDT
During the COVID-19 national public health emergency, we’re working to provide resources and streamline processes so that you can focus on delivering care. This site outlines updates specific to COVID-19 as well as information on any changes to our standard business protocols. For easy access, here are the most frequently requested topics:
To Help Manage Your Business
Updated 10/7/2020 – 6:55 p.m. CDT
Expanded policies around telehealth services make it easier for patients to connect with their health care provider.
Updated 11/25/2020 – 2:30 p.m. CDT
Information to help you with billing for COVID-19 services and to understand reimbursement levels.
Updated 9/30/2020 – 9:00 p.m. CDT
Updates to UnitedHealthcare policies and processes that will help reduce administrative burdens and help patients access care.
Updated 10/26/2020 – 8:00 a.m CDT
Interim processes will help care providers go through the credentialing and contracting process quickly.
Updated 9/16/2020 – 3:00 p.m. CDT
Administrative updates related to the COVID-19 national public health emergency and information on self-service tools.
We’re expanding access to care, support and resources to help our members navigate through this unprecedented time.
The benefits and processes described on this website apply pursuant to federal requirements and UnitedHealthcare national policy during the national public health emergency period. Additional benefits or limitations may apply in some states and under some plans during this time.
We will adjudicate benefits in accordance with the member’s health plan.
Medicaid Providers: UnitedHealthcare will reimburse out-of-network providers for COVID-19 testing-related visits and COVID-19 related treatment or services according to the rates outlined in the Medicaid Fee Schedule.
Care providers can connect to the latest Centers for Disease Control and Prevention (CDC) guidance for health professionals, as well as travel advisories from the U.S. State Department. We’ll continue to add more resources when available.
We’re committed to keeping you up to date on COVID-19 – we’re monitoring your inquiries and working hard to answer your questions. Let us know how we’re doing.
We’ll be making daily updates to this site. Be sure to check back often for the latest information.